Africa manufactures less than 1% of the vaccines it uses, and vaccine trial dist...
Africa Trials
177
US Trials
3,486
Gap Ratio
20x
Nations
54
Key Finding
Africa hosted 177 vaccine trials versus 3,486 in the United States, a 20-fold disparity in research investment.
Regional Comparison
Distribution Analysis
Inequality Profile
Temporal & Structural
Why It Matters
Africa manufactures less than 1% of the vaccines it uses, and vaccine trial distribution reflects this dependency — most trials are sponsored by foreign manufacturers testing products for global markets.
The Evidence 129 words · target 156
In the burden-versus-investment landscape of African health research, does the distribution of vaccine trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Herfindahl-Hirschman concentration index as the primary estimand using registry metadata for each nation. Africa hosted 177 vaccine trials (0.7% of its portfolio) compared to 3,486 in the United States, yielding a 0.0-fold disparity in per-population investment. The Herfindahl-Hirschman index reached 3472.872, exceeding the threshold of 0.25 that indicates a highly concentrated distribution. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.
Sentence Structure
Question
In the burden-versus-investment landscape of African health research, does the distribution of vaccine trials across African nations reveal a systematic research gap?
Dataset
This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.
Method
gov through April 2026.
Primary Result
Investigators computed the Herfindahl-Hirschman concentration index as the primary estimand using registry metadata for each nation.
Robustness
Africa hosted 177 vaccine trials (0.
Interpretation
7% of its portfolio) compared to 3,486 in the United States, yielding a 0.
Boundary
0-fold disparity in per-population investment.
Extra
The Herfindahl-Hirschman index reached 3472.
Extra
872, exceeding the threshold of 0.
Extra
25 that indicates a highly concentrated distribution.
Extra
These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.
Extra
Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.